Expertise in
13
conditions

Dr. Michael Denenberg

Pulmonary Medicine
Office
370 Herlong Ave Ste 200, 
Rock Hill, SC 
Offers Telehealth
Expertise in
13
conditions
Office
370 Herlong Ave Ste 200, 
Rock Hill, SC 

Overview

Michael Denenberg is a Pulmonary Medicine provider in Rock Hill, South Carolina. Dr. Denenberg is highly rated in 13 conditions, according to our data. His top areas of expertise are Emphysema, Bullae, Pleurisy, Pleural Effusion, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pulmonary Medicine

Licenses

Sleep Medicine in SC

Hospital Affiliations

Piedmont Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Office
370 Herlong Ave Ste 200, Rock Hill, SC 29732

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Completed
Publish Date: February 10, 2026
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
Enrollment Status: Terminated
Publish Date: December 03, 2025
Intervention Type: Drug
Study Drug: HZN-825
Study Phase: Phase 2
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of of Tiotropium Bromide Inhalation Solution in Subjects With COPD
A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of of Tiotropium Bromide Inhalation Solution in Subjects With COPD
Enrollment Status: Completed
Publish Date: May 10, 2021
Intervention Type: Drug
Study Drug: Tiotropium Bromide Inhalation Solution
Study Phase: Phase 2
View 6 Less Clinical Trials

3 Total Publications

Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
Journal: Respiratory medicine
Published: July 23, 2017
Similar Doctors
Carl Smart
Expertise in
22
conditions
Dr. Carl Smart
Pulmonary Medicine | Intensive Care Medicine
Expertise in
22
conditions
Dr. Carl Smart
Pulmonary Medicine | Intensive Care Medicine

Novant Health Pulmonary Medicine South - Harrisburg

9550 Rocky River Road, Suite 100, 
Harrisburg, NC 
 (29.0 miles away)
704-316-3612
Experience:
38+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Carl Smart is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Harrisburg, North Carolina. Dr. Smart has been practicing medicine for over 38 years is highly rated in 22 conditions, according to our data. His top areas of expertise are Sarcoidosis, Emphysema, Chronic Cough, and Bullae.

Expertise in
6
conditions
Dr. Thomas Stern
Pulmonary Medicine
Expertise in
6
conditions
Dr. Thomas Stern
Pulmonary Medicine

Weight Loss & Wellness Clinic

16507 Northcross Dr Ste F, 
Huntersville, NC 
 (32.4 miles away)
704-248-0000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Stern is a Pulmonary Medicine provider in Huntersville, North Carolina. Dr. Stern is highly rated in 6 conditions, according to our data. His top areas of expertise are Drowsiness, Narcolepsy, Excessive Daytime Sleepiness, and Obstructive Sleep Apnea.

Expertise in
16
conditions
Dr. Jose E. Perez
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Expertise in
16
conditions
Dr. Jose E. Perez
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Duke Health Lake Norman Hospital

171 Fairview Rd, 
Mooresville, NC 
 (41.9 miles away)
704-660-4000
Languages Spoken:
English
See accepted insurances

Jose Perez is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Mooresville, North Carolina. Dr. Perez is highly rated in 16 conditions, according to our data. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, Hospital-Acquired Pneumonia, and Gastrostomy.

Frequently Asked Questions about Dr. Michael Denenberg

How do I make an appointment with Dr. Michael Denenberg?

You can book an appointment with Dr. Michael Denenberg by calling their office at 803-980-5864. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael Denenberg a top-rated expert for Emphysema?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael Denenberg is classified as an Distinguished expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael Denenberg specialize in?

While Dr. Michael Denenberg is a Pulmonary Medicine, they have specific expertise in Emphysema, Bullae, and Pleurisy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Michael Denenberg participate in research or clinical trials?

Yes. Dr. Michael Denenberg has published 3 articles and abstracts on conditions like Emphysema. You can view a list of Dr. Michael Denenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael Denenberg accept my insurance?

Dr. Michael Denenberg accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 803-980-5864 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Denenberg's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile